Physician
Infectious Disease
Dr. Karam C. Mounzer, MD
|
|
Give Review
Karam C. Mounzer, MD practices Infectious Disease. He went to St Joseph's University Medical School. Karam Mounzer is a published doctor as well. He has 51 publications published. The latest was: Prophylactic use of antibiotics and vaccines in patients with rheumatologic disorders. He is registered with Medicare and accepts Medicare payments.
Publications
- The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Con...
- Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women.
- Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
- PDC and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in Chronically Su...
- Shift in Monocyte Apoptosis with Increasing Viral Load and Change in Apoptosis-related ISG/Bcl2-family Gene Expression in Chronic HIV-1 Infected Subjects.
- Isolated hepatitis B surface antigenemia in an HIV-1-positive individual.
- Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy.
- Preventive cancer screening practices in HIV-positive patients.
- Reply to zur Wiesch and van Lunzen.
- Seminal HIV Blips and Structured Natural Conception In Serodiscordant Couples.
- Safety, Tolerability, and Efficacy of Raltegravir in a Diverse Cohort of HIV-Infected Patients: 48-week Results from the REALMRK Study.
- Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration.
- Constitutive Gene Expression in Monocytes from Chronic HIV-1 Infection Overlaps with Acute Toll-Like Receptor Induced Monocyte Activation Profiles.
- Retinoblastoma protein induction by HIV viremia or CCR5 in monocytes exposed to HIV-1 mediates protection from activation-induced apoptosis: ex vivo and in vitro study.
- Prioritizing CD4 Count Monitoring in Response to ART in Resource-Constrained Settings: A Retrospective Application of Prediction-Based Classification.
- Evidence of a decrease in CD4 recovery once back on antiretroviral therapy after sequential > or =6 weeks antiretroviral therapy interruptions.
- Antiretroviral therapy in HIV-infected patients with multidrug-resistant virus: applying the guidelines to practice.
- Actin integrity is indispensable for CD95/Fas-induced apoptosis of HIV-specific CD8+ T cells.
- Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8(+) T cells.
- HIV-specific CD8+ T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL.
- Vaccinating HIV Patients: Focus on Human Papillomavirus and Herpes Zoster Vaccines.
- Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.
- The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
- Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users.
- Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled st...
- Photo quiz. Infection due to Exophiala jeanselmei.
- Relationship of admission plasma gelsolin levels to clinical outcomes in patients after major trauma.
- Prophylactic use of antibiotics and vaccines in patients with rheumatologic disorders.
- Ehrlichial infections.
- Erectile dysfunction in an urban HIV-positive population.
- HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption.
- IL-13 acutely augments HIV-specific and recall responses from HIV-1-infected subjects in vitro by modulating monocytes.
- Randomized, controlled trial of therapy interruption in chronic HIV-1 infection.
- Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patients.
- Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immu...
- Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendri...
- Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatm...
- Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy.
- Challenge of coadministering antiretroviral therapy and oral anticoagulants in HIV-positive patients.
- HIV type 1 viremia on ART is positively associated with polyclonal T cell proliferation in subjects with T cell IFN-gamma secretion levels comparable to those of uninf...
- Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retentio...
- Thrombotic thrombocytopenic purpura during immune reconstitution.
- Similar efficacy of raltegravir when used with or without a protease inhibitor in treatment-experienced patients.
- Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid.
- Increased metallothionein gene expression, zinc, and zinc-dependent resistance to apoptosis in circulating monocytes during HIV viremia.
- The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients.
- Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and ...
- Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing l...
- Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance.
- Retention of functional DC-NK cross-talk following up to 18 weeks therapy interruptions in chronically suppressed HIV type 1+ subjects.
Schools
Saint Josephs University Faculty of Medicine
Cooper Hospital
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Cooper University Hospital -
St Joseph's University Medical School
Hospital
-
Penn Presbyterian Medical Center
Drug Facts
| NPI NUMBER | 1265571152 | |
| NPPES Provider LastName | MOUNZER | |
| NPPES Provider FirstName | KARAM | |
| NPPES Provider ZIPCode | 19107 | |
| NPPES Provider State | PA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 5747.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 113.0 | |
| Percent Opioid Claims | 1.97 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1265571152 |
| Last Name Of The Provider | MOUNZER |
| First Name Of The Provider | KARAM |
| View All |
Similar Doctors
|
|
Dr. Meredith H. Edwards, MD |
|
|
Dr. Darren R. Linkin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Antonette B. Climaco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James L. Dean, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eileen C. Farnon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amanda M. Michael, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shikata A. Mudakha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marissa B. Wilck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher J. Bruno, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allison J. Sigler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael N. Braffman, MD
This Doctor is OpenDoctor Recommended.
|